-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Initiates Coverage On MBX Biosciences with Sell Rating, Announces Price Target of $18

Benzinga·12/04/2025 12:47:14
语音播报
Goldman Sachs analyst Corinne Johnson initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Sell rating and announces Price Target of $18.